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Abstract  
The spike-wave discharges (SWDs) underlying absence seizures, are generated by hyperactivity of 
T-type voltage sensitive calcium channels (VSCCs) within the cortico-thalamo-cortical network, 
and the first-line drug used in the treatment of absence epilepsy inhibit T-type calcium channels. 
The α2δ subunit associates with all types of VSCCs, including T channels, and facilitates VSCC 
activation. Hence, one expects that drugs that bind to, and inhibit the α2δ subunit, e.g., gabapentin 
and pregabalin, are protective against absence epilepsy and that mice lacking the α2δ subunit are 
resistant to evoked absence seizures. In contrast, gabapentin and pregabalin are not clinically useful, 
and may even be detrimental, in the treatment of absence epilepsy, and ducky mice lacking the α2δ 
subunit develop absence seizures. This suggests that the α2δ subunit displays functions that go 
beyond the regulation of VSCCs, and that these functions are involved in the regulation of the 
cortico-thalamo-cortical network. This viewpoint critically examines the role of the α2δ subunit in 
the pathophysiology of absence seizures focusing on the potential role of the α2δ ligands, 
thrombospondins. 
 
1. Role for the α2δ subunit in the modulation of VSCCs 
VSCCs are formed by a multimolecular complex that includes the α1, β1, γ, and α2δ subunits. The α1 
subunit forms the ion channel and accounts for the basic properties of the channel. Based on the 
specific type of the α1 subunit, VSCCs are classified into T-type (containing the α1G, α1H and α1I 
subunits), L-type (containing the α1C, α1D, α1S, and α1F subunits), P/Q-type (containing the α1A 
subunit), N-type (containing the α1B subunit), and R-type (containing the α1E subunit). There are 
four isoforms of the intracellular β subunit, and eight isoforms of the transmembrane γ subunits, 
which do not confer a particular specificity to the VSCCs, although the γ subunit is preferentially 
found in L-type channels of the skeletal muscle. The γ2 subunit belongs to the group of 
transmembrane AMPA-receptor regulating proteins (TARPs) and is also named stargazine 
(reviewed by Tomita et al., 2007; Kato et al., 2010). Interestingly, stargazer mice lacking the γ2 
subunit show a severe neurological phenotype characterized by ataxia and absence epilepsy (Chen 
et al., 2000; Coombs and Cull-Candy, 2009; Menuz and Nicoll, 2008; Payne, 2008). Convincing 
evidence for the role of this protein in absence epilepsy comes from a study in adult GAERS 
(Genetic Absence Epilepsy Rats of Strasbourg), a well validated genetic absence model (Depaulis et 
al., 2016) , in which it was found that elevated levels of stargazin in the cortical focal region (the 
somatosensory cortex) are associated with an increase in AMPA receptor proteins, GluA1 and 
GluA2. Elevated stargazin expression is not seen in the epileptic WAG/Rij rat (Wistar Albino 
Glaxo rats from Rijswijk), another well described genetic absence model endowed with face, 
construct, and pharmacological validity (Coenen and van Luijtelaar, 2003; Ngomba et al., 2011), 
suggesting that these changes are not likely a consequence of the hundreds daily SWDs, but it might 
be one of the many causal factors that play a role in the occurrence of absence seizures and or in 
epileptogenesis. 
The transmembrane α2δ subunit is formed by the α2 and δ subunits covalently linked by a disulfide 
bridge. Interestingly, the two subunits are generated by a single gene product, which is post-
translationally cleaved. The α2 subunit is glycosylated and interacts extracellularly with the α1 
subunit. The δ subunit has a single transmembrane domain and interacts with anchoring 
intracellular proteins via the C-terminal region (De Jongh et al., 1990). There are four isoforms of 
the α2δ subunit, produced by different genes. α2δ-1, originally described in the skeletal muscle, is 
ubiquitous; α2δ-2 and α2δ-3 are specifically found in neurons, whereas α2δ-4 is non-neuronal. 
The α2δ-1 protein is mainly present in axon terminals of excitatory neurons (Cole et al., 2005), 
whereas the α2δ-2 protein is expressed by cerebellar Purkinje cells (Barclay et al., 2001). The α2δ-3 
protein is ubiquitously expressed in the forebrain (Cole et al., 2005). 
The α2δ subunit regulates the activity of VSCCs by increasing current amplitude and causing a shift 
of voltage-dependent activation towards more hyperpolarized membrane potentials (Arikkath and 
Campbell, 2003; Dolphin, 2003; Cantí et al., 2005; Hendrich et al., 2008; Davies et al., 2010). In 
addition, the α2δ subunit regulates cellular trafficking and membrane expression of VSCCs. 
Accordingly, transient expression of the α2δ-1, -2, and -3 subunits in cultured hippocampal neurons 
targets P/Q channels in presynaptic terminals, thereby enhancing depolarization-evoked 
neurotransmitter release (Hoppa et al., 2012). This mechanism may be particularly relevant under 
pathological conditions, as suggested by the evidence that the α2δ-1 subunit translocates from 
neuronal cell bodies of dorsal root ganglia to axon terminals in the superficial layers of the dorsal 
horns of the spinal cord in a mouse model of neuropathic pain (Bauer et al., 2009). 
 
2. The ambiguous role for the α2δ subunit in absence epilepsy 
a) T-types VSCCs: the key molecular players in absence epilepsy 
Absence seizures, the hallmark of absence epilepsy, are characterized by transient lapses of 
consciousness associated with bilateral symmetrical SWDs in the electroencephalogram (EEG). 
Absence seizures are generated by pathological oscillations in a cortico-thalamo-cortical network 
with a cortical origin; sleep spindles, another type of thalamo-cortical oscillations, are generated in 
the reticular thalamic nucleus, which is part of this network. This SWDs generating network 
includes interconnected pyramidal cells and GABA-ergic interneurons in the somatosensory cortex 
(SSCtx), thalamo-cortical relay cells in the ventrobasal thalamic (VBT) nuclei, and the reticular 
thalamic nucleus (RTN) (reviewed by Blumenfeld, 2005; Avoli and Gloor, 1982; Meeren et al., 
2005; van Luijtelaar et al., 2011). Highly excitable cells in deep layers of the somatosensory cortex 
send excitatory fibers to both the VBT and RTN, VBT neurons in their turn send excitatory fibers to 
the cortical pyramidal neurons and to the GABA-ergic RTN. RTN neurons project to the VBT, and 
are interconnected by gap junction (reviewed by Blumenfeld, 2005; Ngomba et al., 2011; Kohmann 
et al., 2016). 
T-type VSCCs play a critical role in the generation of pathological oscillations underlying the 
electrophysiological correlate of absence seizures, the SWDs. These channels are activated at 
negative membrane potentials by the hyperpolarization-activated cyclic nucleotide-gated cationic I 
h pacemaker channels (HCN), and show a fast voltage-dependent inactivation with respect to other 
VSCCs. Owing to these peculiar functional properties, T channels are involved in the generation of 
repetitive firing in the thalamo-cortical network (Perez-Reyes, 2006; Talavera and Nilius, 2006). In 
the generation of SWDs, an increased excitatory drive from the somatosensory cortex to the RTN 
generates pathological bursts of RTN GABAergic projection neurons leading to GABAB receptor-
mediated inhibitory postsynaptic potentials (IPSPs) in VBT neurons. The resulting 
hyperpolarization enhances the activity of T-type VSCCs in VBT neurons producing the 
pathological 3-4 Hz oscillations that are typical of absence seizures in humans and 7-11 Hz in the 
genetic rat models (reviewed by Blumenfeld, 2005). Based on pioneering in vitro studies it is 
thought that the therapeutic activity of ethosuximide in absence epilepsy occurs via reducing the 
low-threshold Ca2+ current (IT) in thalamocortical neurons (Coulter et al., 1989; Crunelli and 
Leresche, 2002). Although modern views emphasize a leading role for the cortex in the initiation of 
SWDs, the above described thalamic cellular properties, the anatomical projection and an intact 
cortico-thalamo-cortical network remain imperative for SWDs to occur. 
There are three subtypes of T-type channels: CaV3.1, CaV3.2 and CaV3.3, containing the pore-
forming α1G, α1H and α1I subunits, respectively (Catterall et al., 2005). CaV3.2 and CaV3.3 channels 
are expressed in RTN neurons and at least CaV3.3 has been implicated in the generation of RTN 
bursts. CaV3.1 channels are highly expressed in thalamocortical neurons, and all types of T channels 
are found in cortical neurons (Ernst et al., 2009; Cain and Snutch, 2010; Cheong and Shin, 2013). 
 
b) The α2δ subunit associates with T channels and enhances T channel activity in heterologous 
expression systems 
A few studies suggest that the α2δ subunit positively modulates the activity of T channels, although 
the physiological significance of the association between the α2δ subunit and T channels is still 
debated. Overexpression of α2δ influences the voltage-dependence of activation of native T-type 
channels in neuroblastoma/glioma cell lines (Wyatt et al., 1998). In Xenopus oocytes and 
mammalian cells the α2δ subunit enhances membrane expression and current amplitude of T 
channels (Dolphin et al., 1999; Dubel et al., 2004; Thompson et al., 2011). The α2δ subunit can also 
alter the activation and inactivation kinetics and gating properties of T channels (Hobom et al., 
2000; Lacinová and Klugbauer, 2004). 
 
c) The ducky mouse: a counterintuitive association between the lack of α2δ subunit and 
absence epilepsy 
The association between the Cacna2d2 gene and childhood absence epilepsy suggests a role for the 
α2δ subunit in the pathophysiology of absence seizures (Chioza et al., 2009). Because the α2δ 
subunit facilitates the activity of T channels (see above) it is reasonable to predict that the lack of 
the α2δ subunit confers protection against absence seizures. In contrast, ducky mice, characterized 
by a spontaneous loss-of-function mutation of the Cacna2d2 gene, show generalized bilateral 
SWDs with a frequency of 5-7 Hz, and are considered as a genetic model for absence epilepsy 
(Barclay et al., 2001). Ducky mice also show severe ataxia, dyskinesias, dysgenesis of the 
cerebellum and other central nervous system (CNS) regions, axonal dystrophy and demyelination 
(Meier, 1968). Another spontaneous mutation of the Cacna2d2 gene (entla) encodes a mutant form 
of the α2δ-2 protein with an intact C-terminus. This mutation also causes generalized epilepsy (Brill 
et al., 2004), as does a targeted knockout of Cacna2d2 (Ivanov et al., 2004). The epileptic 
phenotype of mice lacking α2δ-2 is counterintuitive if one postulates that the α2δ subunit positively 
modulates T-type channels in thalamic neurons. 
 
d) Lack of therapeutic activity of the two α2δ ligands, gabapentin and pregabalin, in absence 
epilepsy 
Gabapentin and pregabalin have been developed for the treatment of focal epilepsy and are 
currently used in the treatment of neuropathic pain, migraine, anxiety disorders, and bipolar 
disorders (Bialer, 2012; Johannessen Landmark, 2008). Gabapentin and pregabalin bind selectively 
to α2δ-1 and α2δ-2 with nanomolar affinity (reviewed by Cantí et al., 2003; Klugbauer et al., 2003; 
Davies et al., 2007; Lana et al., 2014). An arginine residue in position 217 of α2δ-1 is part of the 
binding pocket, and binding of both [3H]gabapentin and [3H]pregabalin is largely reduced in the 
brain regions of transgenic mice with the α2δ-1 R217A mutation (Gee et al., 1996; Gong et al., 
2001; Hendrich et al., 2008; reviewed by Dooley et al., 2007; Dolphin, 2012). Interaction of 
gabapentin and pregabalin with α2δ has two major effect on VSCCs: (i) a reduced membrane 
localization of α2δ and α1 subunits; and (ii) a reduced calcium channel current. It is generally 
believed that both effects contribute to the therapeutic action of gabapentin and pregabalin in focal 
epilepsy, neuropatic pain, and generalyzed anxiety disorder (Dooley et al., 2007, Stahl et al., 2013). 
By interacting with the α2δ subunit, gabapentin and pregabalin are expected to have therapeutic 
potential in absence epilepsy as a result of T channel inhibition. In contrast, clinical studies have 
consistently shown that the two drugs have no activity in absence epilepsy (Trudeau et al., 1996; 
Chadwick et al., 1996), and gabapentin can precipitate absence and myoclonic status epilepticus 
(Perrucca et al., 1998; Thomas et al., 2006). In animal studies, pregabalin did not affect the 
incidence of SWDs in GAERS (Vartanian et al., 2006) and gabapentin had no effect on absence-
like seizures in the lethargic mouse model of human absence epilepsy (Hosford and Wang, 1997). 
 
3. Potential explanations for the ambiguous role of the α2δ subunit in absence epilepsy 
a) Modulation of non-T type VSCCs 
One possible explanation for the epileptic phenotype of ducky and entla mice is that the loss of α2δ 
subunit causes absence seizures by restraining the activity of high voltage-activated (HVA) Ca2+ 
channels (P/Q, N, L and R channels). Although T channels are one of the major players in the 
generation of pathological oscillations in the cortico-thalamo-cortical network, a large body of 
evidence suggests that HVA channels are also involved in the pathophysiology of absence seizures. 
Pharmacological activation of L-type HVA Ca2+ channels alters the firing rate of thalamocortical 
neurons (Kanyshkova et al., 2014), while the systemic administration of L-type Ca2+ channel 
blocker nimodipine increased SWDs, while a decrease was found after i.c.v. 
(intracerebroventricular) BAY K8644, a L-type Ca2+ channel opener. BAY K8644 was also able to 
antagonise the effects of nimodipine in rats with spontaneous occurring SWDs (van Luijtelaar et al., 
1995; van Luijtelaar et al., 2000). R-type channels are also involved in the generation of oscillatory 
burst discharges in RTN neurons and absence epilepsy (Zaman et al., 2011). Preliminary evidence 
for a role in the R-type Ca2+ blocker was obtained after the administration of the conotoxin GVIA, it 
reduced SWDs (van Luijtelaar et al., 2000). Mutations of the Cacna1a gene encoding for the α1 
subunit of P-type channels are associated with absence seizures in rodents and humans (Burgess and 
Noebels, 1999; Zamponi et al., 2010; Serikawa et al., 2015). It is possible that in ducky mice a 
reduced expression/activity of HVA VSCCs causes a componsatory increase in the activity of T-
type channels resulting into absence seizures. 
 
b) Beyond VSCCs: the α2δ subunit mediates the action of thrombospondins in the CNS 
The α2δ subunit is the receptor for a class of proteins, called thrombospondins (TSPs) , which were 
first isolated from platelets stimulated with thrombin and show a widespread distribution in various 
organs, including the CNS. TSPs are a large oligomeric extracellular matrix (ECM) proteins, found 
in vertebrates and lower metazoa (Adams, 2001; Bentley and Adams, 2010; Mosher and Adams, 
2012). The human TSP protein family consists of five members (TSP-1, TSP-2, TSP-3, TSP-4, and 
TSP-5, or COMP, cartilage oligomeric matrix protein) which are subdivided into two groups 
(Adams, 2001; Adams and Lawler, 2004; Adams and Lawler, 2011) on the basis of their 
oligomerization state and domain structure. Subgroup A includes TSP-1 and TSP-2, which form 
homotrimers; subgroup B includes TSP-3, TSP-4, and TSP-5, which form homopentamers (Lawler, 
2002). The various isoforms of TSPs are the products of different genes, and display differential 
non-overlapping functions (Stenina-Adognravi, 2013). 
TSPs primarily regulate cell-cell and cell-extracellular matrix interactions (Bornstein, 2000) acting 
through a number of ECM proteins and cell surface receptors and controlling cytoskeletal 
dynamics, cell migration, and cell attachment (Bornstein et al., 2004). All these activities regulate 
many aspects of cell phenotype and contribute to angiogenesis and wound healing, vessel wall 
biology and synaptogenesis (Adams and Lawler, 2011). 
Astrocyte-secreted TSP-1, TSP-2 promote synaptogenesis in cultured hippocampal neurons (Xu et 
al., 2010) and retinal ganglion cells (Christopherson et al., 2015), and TSP-1 can also promote 
neuronal migration (Iruela-Arispe et al., 1993) and axonal growth (Yu et al., 2008). TPS-1 and TSP-
2 are highly expressed during development (Christopherson et al., 2005; Xu et al., 2010; Cahoy et 
al., 2008) and acts in specific time windows to promote synaptogenesis in the developing brain. 
TSP-4 is exclusively expressed by mature astrocytes, and represents the mature TSP isoform in the 
CNS (Bornstein et al., 2004). 
Eroglu et al. (2009) have shown for the first time that the synaptogenic epidermal growth factor 
(EGF)-like repeat domains of TSPs interact with the VWF-A (von Willebrand factor) domain of 
α2δ-1. This interaction mediates the synaptogenic activity of TSPs. Accordingly, overexpression of 
α2δ-1 enhanced synaptogenesis in mice, and the α2δ ligand, gabapentin, restrained the synaptogenic 
activity of TSPs (Eroglu et al., 2009). 
A potential link between alterations in synaptogenesis and absence epilepsy is suggested by the 
evidence that stargazin mutation in mice causes an impairment in synaptic formation and 
maturation in the cerebellum (Meng et al., 2006). In addition, double mutant zi/zi, tm/tm rats, which 
spontaneously develop absence seizures after 6 weeks of age, show a low expression of the synaptic 
vesicle proteins, SV2A and synaptotagmin-1 (Hanaya et al., 2012). We have found a selective 
reduction of the transcript encoding for TSP-1 in the ventrobasal thalamus of WAG/Rij (Santolini et 
al., 2015), which represent a validated genetic rat model of human absence epilepsy (van Luijtelaar 
and Coenen, 1986; 1997). 
An attractive hypothesis is that the TSP-α2δ axis plays a key role in synaptic formation within the 
cortico-thalamo-cortical network that lies at the core of the pathophysiology of absence epilepsy 
(Blumenfeld, 2005) and that defects in either TSPs or α2δ disrupt synaptic organization in the circuit 
resulting into absence seizures. TSPs may have a broader role in epileptogenesis that involves other 
types of epilepsy. Mendus et al. (2015) have recently found that mice with genetic deletion of TSP-
1 show an increased sensitivity to chemical kindling induced by repeated administrations of a 
subconvulsive dose of pentylenetetrazole (PTZ). TSP-1 knockout mice developed generalyzed 
tonic-clonic seizures in response to the second administration of PTZ, whereas at least eight 
administrations were required to produce the same phenotype in wild-type mice (Mendus et al., 
2015). Interestingly, TSP-1 knockout mice also showed a reduced expression of both α2δ-1 and α2δ-
2 subunits in the frontal cotex (Mendus et al., 2015). 
In conclusion, the α2δ subunit subserves pleiotropic functions that may be relevant for the 
pathophysiology of epilepsy and may be targeted by therapeutic intervention. The role of α2δ 
subunit in absence epilepsy cannot be reconducted to the modulation of T-type channels, and may 
involve other types of VSCCs. Increasing evidence suggests that the TSP-α2δ axis can be 
dysfunctional in absence epilepsy and other forms of epilepsy. Abnormalities in either TSPs and/or 
α2δ subunit may contribute to the process of epileptogenesis, which is ultimately responsible for the 
recurrence of epileptic seizures. If proven to be correct, this may lay the groundwork for the design 
of novel disease modifying drugs that are directed towards mechanisms that lie at the core of 
epileptogenesis. 
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